BAYER HEALTHCARE has a total of 17 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are GEISINGER CLINIC, EXONHIT THERAPEUTICS SA and XENON GENETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Poland | 2 | |
#5 | Uruguay | 2 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Japan | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Machines | |
#5 | Organic fine chemistry | |
#6 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Diby Kouakou | 5 |
#2 | Mallon Paula | 5 |
#3 | Banta Judith | 5 |
#4 | Baker Lawrence A | 5 |
#5 | Freeman James V | 5 |
#6 | Pastorek Jaromir | 3 |
#7 | Erdogan Seyda | 3 |
#8 | Pastorekova Silvia | 3 |
#9 | Zavada Jan | 2 |
#10 | Soyupak Buelent | 2 |
Publication | Filing date | Title |
---|---|---|
EP1743038A2 | Mn/ca ix/ ca9 and renal cancer prognosis | |
WO2005037083A2 | Mn/ca ix and cancer prognosis | |
US2004209375A1 | Control bracketing and results hold | |
AU2002308071A1 | Regulation of human phosphatidic acid phosphatase type 2c-like protein |